104 related articles for article (PubMed ID: 9010096)
1. The significance of allelic deletions and aneuploidy in colorectal carcinoma. Results of a 5-year follow-up study.
Cohn KH; Ornstein DL; Wang F; LaPaix FD; Phipps K; Edelsberg C; Zuna R; Mott LA; Dunn JL
Cancer; 1997 Jan; 79(2):233-44. PubMed ID: 9010096
[TBL] [Abstract][Full Text] [Related]
2. DNA ploidy and S-phase fraction, but not p53 or NM23-H1 expression, predict outcome in colorectal cancer patients. Result of a 5-year prospective study.
Bazan V; Migliavacca M; Zanna I; Tubiolo C; Corsale S; Calò V; Amato A; Cammareri P; Latteri F; Grassi N; Fulfaro F; Porcasi R; Morello V; Nuara RB; Dardanoni G; Salerno S; Valerio MR; Dusonchet L; Gerbino A; Gebbia N; Tomasino RM; Russo A
J Cancer Res Clin Oncol; 2002 Dec; 128(12):650-8. PubMed ID: 12474051
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of the loss of heterozygosity of Nm23-H1 and p53 genes in human colorectal carcinomas.
Campo E; Miquel R; Jares P; Bosch F; Juan M; Leone A; Vives J; Cardesa A; Yague J
Cancer; 1994 Jun; 73(12):2913-21. PubMed ID: 8199988
[TBL] [Abstract][Full Text] [Related]
4. Nm23-H1 protein, DNA-ploidy and S-phase fraction in relation to overall survival and disease free survival in transitional cell carcinoma of the bladder.
Alderisio M; Cenci M; Valli C; Russo A; Bazan V; Dardanoni G; Cucciarre S; Carreca I; Macaluso MP; Tomasino RM; Vecchione A
Anticancer Res; 1998; 18(6A):4225-30. PubMed ID: 9891471
[TBL] [Abstract][Full Text] [Related]
5. c-erbB-2, p53, and nm23 proteins as prognostic factors in patients with epithelial ovarian carcinoma.
Tomić S; Ilić Forko J; Babić D; Sundov D; Kuret S; Andelinović S
Croat Med J; 2003 Aug; 44(4):429-34. PubMed ID: 12950146
[TBL] [Abstract][Full Text] [Related]
6. [Correlation study of allelic gene deletion of nm23-H1 and human colorectal carcinoma metastasis].
Xu W; Bai J; Yang D
Zhonghua Zhong Liu Za Zhi; 1995 Jul; 17(4):263-5. PubMed ID: 7587891
[TBL] [Abstract][Full Text] [Related]
7. Prediction of distant metastases after curative surgery for rectal cancer.
Günther K; Dworak O; Remke S; Pflüger R; Merkel S; Hohenberger W; Reymond MA
J Surg Res; 2002 Mar; 103(1):68-78. PubMed ID: 11855920
[TBL] [Abstract][Full Text] [Related]
8. Immunohistological p53 staining is of limited value in the staging and prognostic prediction of colorectal cancer.
Kressner U; Lindmark G; Gerdin B; Påhlman L; Glimelius B
Anticancer Res; 1996; 16(2):951-7. PubMed ID: 8687158
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of NDP kinase nm23 associated with ploidy image analysis in colorectal cancer.
Giarnieri E; Alderisio M; Valli C; Vecchione A; Forte A; Turano R; Pulcini M
Anticancer Res; 1995; 15(5B):2049-53. PubMed ID: 8572601
[TBL] [Abstract][Full Text] [Related]
10. Expression of nm23-H1 in transitional cell carcinoma of the upper urinary tract.
Cheng HL; Tong YC; Tzai TS; Weng CL; Ho CL; Yang WH; Lin JS; Chow NH
Oncol Rep; 2001; 8(1):193-6. PubMed ID: 11115597
[TBL] [Abstract][Full Text] [Related]
11. Separating favorable from unfavorable prognostic markers in breast cancer: the role of E-cadherin.
Heimann R; Lan F; McBride R; Hellman S
Cancer Res; 2000 Jan; 60(2):298-304. PubMed ID: 10667580
[TBL] [Abstract][Full Text] [Related]
12. Influence of the c-erb B-2, nm23, bcl-2 and p53 protein markers on colorectal cancer.
Demirbaş S; Sücüllü I; Yildirim S; Celenk T
Turk J Gastroenterol; 2006 Mar; 17(1):13-9. PubMed ID: 16830272
[TBL] [Abstract][Full Text] [Related]
13. NM23 expression as prognostic factor in colorectal carcinoma.
Forte A; D'Urso A; Gallinaro LS; Lo Storto G; Soda G; Bosco D; Bezzi M; Vietri F; Beltrami V
G Chir; 2002 Mar; 23(3):61-3. PubMed ID: 12109225
[TBL] [Abstract][Full Text] [Related]
14. P53 is a regulator of the metastasis suppressor gene Nm23-H1.
Chen SL; Wu YS; Shieh HY; Yen CC; Shen JJ; Lin KH
Mol Carcinog; 2003 Apr; 36(4):204-14. PubMed ID: 12669312
[TBL] [Abstract][Full Text] [Related]
15. The nm23-H1 gene as a predictor of sensitivity to chemotherapeutic agents in oesophageal squamous cell carcinoma.
Iizuka N; Hirose K; Noma T; Hazama S; Tangoku A; Hayashi H; Abe T; Yamamoto K; Oka M
Br J Cancer; 1999 Oct; 81(3):469-75. PubMed ID: 10507772
[TBL] [Abstract][Full Text] [Related]
16. Nm23 'anti-metastatic' gene product expression in colorectal carcinoma.
Royds JA; Cross SS; Silcocks PB; Scholefield JH; Rees RC; Stephenson TJ
J Pathol; 1994 Mar; 172(3):261-6. PubMed ID: 8195929
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of nm23-H1 expression in esophageal squamous cell carcinoma.
Wang LS; Chow KC; Lien YC; Kuo KT; Li WY
Eur J Cardiothorac Surg; 2004 Aug; 26(2):419-24. PubMed ID: 15296908
[TBL] [Abstract][Full Text] [Related]
18. [The expression and significance of heparanase and nm23-H1 in hepatocellular carcinoma].
Liu Y; Chen X; Peng S; Fang H; Wu Y; Peng C; Shi L; Bai M; Xu B; Wang J; Deng G
Zhonghua Yi Xue Za Zhi; 2002 Nov; 82(22):1553-6. PubMed ID: 12609066
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of Nm23/NDPK expression in breast carcinoma, assessed on 10-year follow-up by automated and quantitative immunocytochemical assays.
Charpin C; Garcia S; Bonnier P; Martini F; Andrac L; Horschowski N; Lavaut MN; Allasia C
J Pathol; 1998 Apr; 184(4):401-7. PubMed ID: 9664906
[TBL] [Abstract][Full Text] [Related]
20. Genetic instability, p53 and nm23 mutation and clinicopathological features in rectal carcinoma.
Indinnimeo M; Cicchini C; Stazi A; Mingazzini P; Caligo MA; Ghimenti C; Bevilacqua G
Anticancer Res; 1998; 18(2A):989-93. PubMed ID: 9615752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
